Gadoversetamide Production Cost Reports

The report provides a detailed analysis essential for establishing a Gadoversetamide production plant. It encompasses all critical aspects necessary for Gadoversetamide production, including the cost of Gadoversetamide production, Gadoversetamide plant cost, Gadoversetamide production costs, and the overall Gadoversetamide production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Gadoversetamide production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Gadoversetamide is a medical contrast agent mainly used to improve the quality of MRI scans. It is given during tests that involve the brain, spine, and other soft tissues, where sharper images are needed to detect growths, injuries, or infection. It helps highlight soft tissues, blood vessels, and organs so that doctors can detect health problems with greater clarity. It also finds its application in clinical research to study new imaging methods and compare the performance of different contrast agents. It is used for cases that require accurate visualisation of blood vessels and fluid pathways, which improves the quality of information available for treatment planning.

The demand for Gadoversetamide is mainly led by its application as an MRI contrast agent to facilitate and enhance various diagnostic procedures, which fuels its market expansion. Its involvement in diagnostic imaging to support the examination of the brain, spine, and other internal areas significantly boosts its demand in the medical and diagnostics industries. Its use in clinical studies evaluating improved imaging methods, compared with different contrast materials, also contributes to its steady market growth.

Its role in diagnosing brain, spine, and vascular conditions further strengthens demand across hospitals, imaging centres, along the medical sector. Factors such as the availability of raw inputs, production costs, adherence to medical safety rules, and strict purity requirements play a major part in shaping industrial Gadoversetamide procurement globally. In addition, reliable transport systems, ongoing progress in imaging technology, and careful handling standards also impact its procurement needs and market worldwide.

Raw Material for Gadoversetamide Production

According to the Gadoversetamide production plant project report, the major raw materials for Gadoversetamide production include Diethylenetriaminepentaacetic acid dianhydride (DTPA dianhydride)- 2-Methoxyethylamine and Gadolinium(III) oxide (Gd2O3).

Production Process of Gadoversetamide

The extensive Gadoversetamide production cost report consists of the following industrial production processes:

1. Production via Chemical Synthesis: The production process of Gadoversetamide begins with preparing the chelating ligand by reacting diethylenetriaminepentaacetic acid dianhydride with 2-methoxyethylamine in warm isopropanol until it forms a clear solution. After removing undissolved material, the solvent is evaporated, and the residue is dried to give the ligand in solid form. Then, this ligand is combined with gadolinium oxide in water and gently heated until the metal fully dissolves and forms a uniform complex. Further, the solution is filtered and poured into acetone to precipitate the crude gadolinium complex, which is collected, washed, and redissolved in methanol. Then, the mixture is subjected to further concentration and reprecipitation in acetone to obtain a cleaner solid. Finally, the material is purified by crystallising it from a mixture of methanol and tetrahydrofuran, which results in the production of Gadoversetamide as a high-purity solid product.

Gadoversetamide is a non-volatile, aqueous-soluble pharmaceutical agent. It appears as a white, odourless crystalline powder that dissolves freely in water. Its molecular formula is C20H34GdN5O10, and its molar mass is approximately 661.76 g/mol. The density of the compound is about 1.160 g/cm³. The compound decomposes prior to liquefaction, and it is a chelated gadolinium complex and not a simple volatile substance. It is recommended to handle the compound carefully because it contains the paramagnetic Gadolinium(III) ion. Protective clothing, eye protection and gloves are recommended when handling the dry material to avoid dust inhalation or inadvertent contact. Excessive exposure to gadolinium compounds may lead to adverse effects in patients with kidney impairment.